This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Featured Suppliers

Featured
Lumenous Device Technologies
Featured
Master Bond Inc.
Featured
Aptyx

Interface Biologics

Interface Biologics (IBI) develops novel biomedical polymer technologies that enhance the safety and effectiveness of implantable medical devices by reducing thrombosis, inhibiting infection and providing programmable delivery of pharmaceuticals and biologics. Endexo anti-thrombogenic technology encompasses a range of low molecular weight additives for reduced thrombus formation on devices without the use of heparin. Endexo is compatible with a wide-range of medical grade polymers and processing methods (ex. injection molding, solution spinning or extrusion). The additives self-migration properties introduce a permanent passive surface modification disturbing the adsorption of blood proteins and activation of platelets.

Sign In

Not Signed In

Please sign in or create a free account to request information

Create an Account

Not Signed In

Please sign in or create a free account to save your favorites

Create an Account